Asia-Pacific Influenza Market estimated to reach $2.18 billion by 2021 with a CAGR of 10.70%

The Asia-Pacific ‘Influenza Market' research report, published by Market Data Forecast estimates that the market itself was worth $1.31 billion in 2016 and expected to grow at a CAGR of 10.70%, to reach $2.18 billion by 2021.

Influenza, or flu, is a respiratory illness caused by a virus. Flu is highly contagious and is normally spread by the coughs and sneezes of an infected person.

You can also catch flu by touching an infected person, for instance, shaking hands. Adults are contagious 1-2 days before getting symptoms and up to 7 days after becoming ill. This means that you can spread the influenza virus before you even know you are infected.

Request Sample : http://www.marketdataforecast.com/market-reports/asia-pacific-influenza-market-1707/request-sample

Over 200,000 people are hospitalized from flu complications each year, and about 36,000 people are estimated to die as a result of flu. It is estimated that 250,000-500,000 people die each year as a result of flu. In industrialized countries, the majority of deaths occur among people over the age of 65.
A flu epidemic - where a large number of people in one country are infected - can last several weeks.

Customize the report: http://www.marketdataforecast.com/market-reports/asia-pacific-influenza-market-1707/customize-report

The report also presents detailed analysis of multitude of factors affecting the Influenza market bearing either positive or negative outcomes. Some of those factors are:

• Rising public awareness
• Boost in healthcare expenditure
• Cost-effectiveness of immunization
• Introduction of new medicines
• Increasing government initiatives for vaccination against influenza viruses
• A large section of population, in Asia-Pacific not being immunized against influenza virus, thereby fueling the demand for the product
• Antigenic shift of influenza virus
• Lack of cold storage facility
• Side-effects of product (soreness, allergic reactions, swelling, and redness)
• Remote areas with limited accessibility.

Inquire Before Buying: http://www.marketdataforecast.com/market-reports/asia-pacific-influenza-market-1707/inquire

For granular level understanding the Influenza Market is segmented based on product and application, each being provided with Market Size Estimates and Y-o-Y Forecasts. Asia-Pacific Influenza Market is segmented on the basis of Product Type and Consumer. Based on Product Type, the market is classified into vaccines and drugs. On the basis of Consumer, the market is classified into Children and Adults.

Buy now: http://www.marketdataforecast.com/cart/buy-now/asia-pacific-influenza-market-1707

On the basis of geography, the Asia-pacific Influenza market is segmented into the countries China, India, Japan, and South Korea. The Influenza market in Asia-Pacific is growing fast due to the increasing awareness regarding healthcare.

Request Discount: http://www.marketdataforecast.com/market-reports/asia-pacific-influenza-market-1707/request-discount

The major companies dominating Asia-Pacific Influenza Market are Sanofi-Pasteur (U.S.), AstraZeneca (United Kingdom), F. Hoffmann-La Roche (Switzerland), Novartis (Switzerland), GlaxoSmithKline (U.K.), Pfizer Inc. (U.S.), Merck & Co. (U.S.), Abbott Laboratories (U.S.), Mitsubishi Tanabe Pharma Corporation (Japan), CSL Limited (Australia).

Checkout other related studies in the Pharmaceuticals Segment:

Anti-fungal drugs Market: http://www.marketdataforecast.com/market-reports/global-anti-fungal-drugs-market-242/

Antivenom Market: http://www.marketdataforecast.com/market-reports/global-antivenom-market-1580/

The Asia-Pacific Influenza Market report offers wide-range of scope:
• Regional and country-level analysis that provides an individual perspective of Asia-Pacific region and the aforementioned countries
• Know more about key areas of industry growth via detailed Segment-level analysis on basis of product type long with market size forecasts and y-o-y estimations
• Detailed explanation of major drivers, restraints, opportunities, and challenges(DROC) that affect the market and impact the ever-shifting market dynamics
• Strategic Analyses containing PESTLE and Porter’s Five Forces Analyses which are obtained by studying the macro & micro environmental factors that affect the market demographics
• Comprehensive listing of key market players along with Company overview, product portfolios, financials (subjected to availability), SWOT analysis and analyst overview
• Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
• Market Outlook - Investment opportunities devised by stand in experts to provide both individuals and organizations a strong financial foothold in the market

About Market Data Forecast:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options. For more info kindly visit, www.marketdataforecast.com

Contact:
Abhishek Shukla
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Mail:abhishek@marketdataforecast.com
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases

This release was published on openPR.